Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC ...

WASHINGTON -- House Republicans unveiled a budget proposal that includes an estimated $715 billion in cuts to Medicaid and ...

Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

"Antihypertensive medication administration time did not affect the risks and benefits of blood pressure-lowering medication ...

Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab ...

Means argues that the cause of most health conditions -- including cancer, Alzheimer's disease, obesity, erectile dysfunction ...

Like many of the almost 100,000 medical students in the U.S., I enrolled in medical school having grown up infatuated with ...

Tacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or ...

President Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of ...

The FDA and NIH announced a joint nutrition research venture to better understand the causes of diet-related chronic disease, ...

Early findings from the SPARTAN phase II trial, presented at the National Kidney Foundation (NKF) Spring Clinical Meeting, ...